Zacks Investment Research
03 Sept 2026, 14:55 UTC · 4d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
2 claims · each scored for market impact
Wall Street analysts have a mean price target of $33.17 for Adicet Bio (ACET), implying a 258.2% upside from its current price of $9.26. — A significant positive consensus among analysts typically attracts speculative buying and improves sentiment for a small-cap stock.
+0.60Analysts are in agreement that Adicet Bio (ACET) will report earnings that exceed previous estimates. — Positive earnings revisions are a strong fundamental indicator of improving company performance and often precede price increases.
+0.40Which stocks this story touches
Analysts have set a mean price target indicating 258.2% upside potential and positive earnings estimate revisions.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
2d ago
